Actavis Group receives FDA acceptance to advertise Bupropion HCl SR tablets Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U Read more about this drug .S. Food & Medication Administration to advertise Bupropion HCl Extended-Launch tablets 100mg and 200mg.S. The addition of the 100mg and 200mg Bupropion HCl SR complements Actavis’ already approved and marketed Bupropion HCl SR 150mg. Actavis received acceptance of Bupropion HCl SR 150mg in March, 2008.’.
‘The acquisition of Auden Mckenzie is certainly a strategic combination that makes Actavis the main generic business in the united kingdom and aligns with this strategy to set up a leading position in all of our markets, franchises and therapeutic classes,’ said Brent Saunders, CEO and President of Actavis. ‘Auden Mckenzie's knowledge in the advancement and commercialization of quality value, technically demanding formulations as well as specialized and market opportunities is complementary to and expands Actavis' UK business concentrate,’ said Robert Stewart, Executive Vice President Actavis, and President, Global and Generics Operations. ‘The opportunity to mix this profitable and growing company in to the Actavis UK business demonstrates our dedication to purchase and expand strategically inside our global generics business.’..